Skip to content

Patients' entrance skin doses during percutaneous coronary intervention for chronic total occlusion

Patients' entrance skin doses during percutaneous coronary intervention for chronic total occlusion - ESD during PCI for CTO

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000000490
Enrollment
120
Registered
2007-12-01
Start date
2005-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic total occlusion

Interventions

None listed

Sponsors

Radiological Protection During PCI Conference
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients must be scheduled for PCI for CTO based on clinical indication

Exclusion criteria

Exclusion criteria: 1. Patients scheduled for PCI, in which the upper arm may included in the irradiation field 2. Patient with skin lesion on the back which can be confused with radiation induced skin injury before the PCI procedure 3. Inability to sit before PCI prpcedure 4. Functional CTO

Design outcomes

Primary

MeasureTime frame
patients' entrans skin dose

Secondary

MeasureTime frame
data of PCI, radiation induced skin injury

Countries

Japan

Contacts

Public ContactShigeru Suzuki

Teikyo University school of Medicine Department of Radiology

s-suzuki@med.teikyo-u.ac.jp03-3964-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026